Viewing Study NCT06409104

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 8:00 PM
Ignite Modification Date: 2026-01-31 @ 8:23 PM
Study NCT ID: NCT06409104
Status: COMPLETED
Last Update Posted: 2024-05-14
First Post: 2024-05-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Propofol Versus Dexmedetomidine for Sedation of Cancer Patients Undergoing ERCP
Sponsor: National Cancer Institute, Egypt
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sedation in ERCP View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ERCP View
None Endoscopic View
None cancer View
None sedation View
None propofol View
None Dexmedetomidine View